International Nonproprietary Names for Pharmaceutical Substances (INN)
- Published in:
- 2005
- Publication type:
- Journal Article
Works matching IS 10109609 AND DT 2005 AND VI 19 AND IP 4
Results: 45
1
2
Launch of new medicines website.
- Published in:
- 2005
- Publication type:
- Journal Article
3
International Nonproprietary Names for Pharmaceutical Substances (INN).
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 315
- Publication type:
- Article
4
Recent publications, information and events.
- Published in:
- 2005
- Publication type:
- Journal Article
5
Regulatory action and news.
- Published in:
- 2005
- Publication type:
- Journal Article
6
Priority medicines for Europe and the world.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 308
- Publication type:
- Article
7
Chronic airways disease guide.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 308
- Publication type:
- Article
8
Canada and the 'Jean Chrétien pledge to Africa'.
- Published in:
- 2005
- Publication type:
- Journal Article
9
Launch of new medicines website.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 312
- Publication type:
- Article
10
Monograph for oral powders.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 309
- Publication type:
- Article
11
Safety and efficacy issues.
- Published in:
- 2005
- Publication type:
- Journal Article
12
Avian influenza: impact on health programmes.
- Published in:
- 2005
- Publication type:
- Journal Article
13
The Blue Guide on advertising.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 307
- Publication type:
- Article
14
Screening guidelines for women exposed to DES in utero.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 307
- Publication type:
- Article
15
Sources and prices of HIV medicines and diagnostics.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 306
- Publication type:
- Article
16
Registration of fixed dose combinations.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 306
- Publication type:
- Article
17
Promoting drug use in the community.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 306
- Publication type:
- Article
18
Environmental risk assessment for human and veterinary medicinal products.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 304
- Publication type:
- Article
19
Precautionary suspension of Hexavac: lowered immunogenicity.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 304
- Publication type:
- Article
20
Withdrawal of Infanrix HepB.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 303
- Publication type:
- Article
21
EMEA proposes new, faster scientific advice procedure.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 303
- Publication type:
- Article
22
Nelarabine approved for leukaemia and lymphoma.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 303
- Publication type:
- Article
23
Pemoline: liver Injury risk and market withdrawal.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 302
- Publication type:
- Article
24
Veralipride: withdrawal following review of risk/benefit.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 302
- Publication type:
- Article
25
International biosafety guidelines for influenza vaccine production.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 301
- Publication type:
- Article
26
Influenza virus composition for 2006 southern hemisphere winter.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 301
- Publication type:
- Article
27
Safety update on paediatric use of oseltamivir.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 301
- Publication type:
- Article
28
Canada and the "Jean Chrétien Pledge to Africa".
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 296
- By:
- Publication type:
- Article
29
Paroxetine: first trimester exposure and congenital malformations.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 295
- Publication type:
- Article
30
Atomoxetine and suicidal thinking in children and adolescents.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 294
- Publication type:
- Article
31
Liquid chemical polymer and serious adverse events.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 294
- Publication type:
- Article
32
Interactions with implantable medical devices.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 293
- Publication type:
- Article
33
Ibritumomab tiuxetan therapeutic regimen: cutaneous reactions.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 293
- Publication type:
- Article
34
Intrathecal baclofen: incidents with implantable drug pump system.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 292
- Publication type:
- Article
35
Duloxetine hydrochloride and hepatic effects.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 292
- Publication type:
- Article
36
Oseltamivir paediatric adverse events.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 291
- Publication type:
- Article
37
Trastuzumab: interim treatment recommendations.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 291
- Publication type:
- Article
38
Trastuzumab and possible cardiotoxicity.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 291
- Publication type:
- Article
39
Meningococcal vaccine and Guillain Barre syndrome.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 290
- Publication type:
- Article
40
New safety information on long-acting beta-2 agonists.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 289
- Publication type:
- Article
41
Statins and memory loss.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 288
- Publication type:
- Article
42
WHO International Drug Monitoring Programme: 28th meeting.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 287
- Publication type:
- Article
43
Safety challenges of preventing malaria during pregnancy.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 286
- By:
- Publication type:
- Article
44
Influenza antiviral medicinal products for potential use during a pandemic.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 274
- Publication type:
- Article
45
Avian influenza: impact on health programmes.
- Published in:
- WHO Drug Information, 2005, v. 19, n. 4, p. 273
- Publication type:
- Article